Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Deferred Taxes (2023 - 2024)

Historic Deferred Taxes for Perspective Therapeutics (CATX) over the last 2 years, with Q4 2024 value amounting to -$2.1 million.

  • Perspective Therapeutics' Deferred Taxes fell 12671.68% to -$2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.1 million, marking a year-over-year increase of 2089.78%. This contributed to the annual value of -$2.1 million for FY2024, which is 2089.78% up from last year.
  • Latest data reveals that Perspective Therapeutics reported Deferred Taxes of -$2.1 million as of Q4 2024, which was down 12671.68% from $7.8 million recorded in Q4 2023.
  • Perspective Therapeutics' 5-year Deferred Taxes high stood at $7.8 million for Q4 2023, and its period low was -$10.5 million during Q1 2023.